MedCap AB (publ)
STO:MCAP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
MedCap AB (publ)
Cash & Cash Equivalents
MedCap AB (publ)
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
MedCap AB (publ)
STO:MCAP
|
Cash & Cash Equivalents
kr370.4m
|
CAGR 3-Years
16%
|
CAGR 5-Years
20%
|
CAGR 10-Years
18%
|
|
|
AddLife AB
STO:ALIF B
|
Cash & Cash Equivalents
kr813m
|
CAGR 3-Years
29%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
BICO Group AB
STO:BICO
|
Cash & Cash Equivalents
kr1.2B
|
CAGR 3-Years
9%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
A
|
AroCell AB (publ)
STO:AROC
|
Cash & Cash Equivalents
kr36.6m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
Biotage AB
STO:BIOT
|
Cash & Cash Equivalents
kr420m
|
CAGR 3-Years
6%
|
CAGR 5-Years
13%
|
CAGR 10-Years
13%
|
|
|
G
|
Genovis AB
STO:GENO
|
Cash & Cash Equivalents
kr163.2m
|
CAGR 3-Years
31%
|
CAGR 5-Years
30%
|
CAGR 10-Years
55%
|
|
MedCap AB (publ)
Glance View
MedCap AB is an investment company engaged in biotechnology and medical technology capital investments. The company is headquartered in Solna, Stockholm. The company went IPO on 2006-07-04. The firm reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.
See Also
What is MedCap AB (publ)'s Cash & Cash Equivalents?
Cash & Cash Equivalents
370.4m
SEK
Based on the financial report for Dec 31, 2025, MedCap AB (publ)'s Cash & Cash Equivalents amounts to 370.4m SEK.
What is MedCap AB (publ)'s Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
18%
Over the last year, the Cash & Cash Equivalents growth was 0%. The average annual Cash & Cash Equivalents growth rates for MedCap AB (publ) have been 16% over the past three years , 20% over the past five years , and 18% over the past ten years .
